NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) Stock Price, Quote & AI Analysis
Live NRSN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for NeuroSense Therapeutics Ltd. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
NeuroSense Therapeutics Ltd. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
NeuroSense Therapeutics Ltd. Ordinary Shares Overview
Company information
Company Overview
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
NeuroSense Therapeutics Ltd. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...